Background and objectives: Relaxin (RLN) is an insulin-like hormone associated with extracellular matrix degradation, osteoclastogenesis, and osteoblast differentiation. This study aimed to assess the effect of RLN during and after lateral expansion of murine calvarial sagittal sutures. Materials and methods: RLN was injected topically using a nano-sized liposome carrier into the sagittal sutures of 8-to 10-week-old wild type mice just before lateral expansion. Suture morphology, bone mineral density (BMD), and bone volume were analysed by micro-computed tomography. Collagen deposition and osteoclast differentiation were observed by Verhoeff-Van Gieson (VVG) and tartrate-resistant acid phosphatase (TRAP) staining, respectively. Results: Less collagen staining and higher tissue-specific relaxin/insulin-like family peptide receptor (Rxfp)-1 and -2 expression were observed in the RLN-treated samples after 48 hours. Increased BMD and volume, and thick well-organised osteoid tissue, with multinucleated TRAPpositive cells, were observed in RLN-treated samples after 1 week. Increased Rxfp-1 expression was observed in the sagittal sutures in the mid-suture fibrous tissue following RLN treatment. Rxfp-2 was only expressed in the calvarial bone under tensile stimulation and RLN treatment further increased its expression. Limitations: RLN-liposomes were not detected at any instance under the current experimental conditions. This is a preliminary study and the sample number limits the power of its results. VVG staining cannot quantify collagen contents but can provide preliminary information on the presence of collagen fibres. Conclusions: RLN treatment may modify bone remodelling and collagen metabolism during and after suture expansion.
Introduction
Mid-palatal suture expansion is commonly practiced by orthodontists to laterally expand the maxillary dental arch to correct dental crowding (1, 2) . Complications of this procedure include limited expansion range and relapse (3, 4) . Relapse is caused by the tension exerted by the distended connective tissue of the suture and failure to produce a stable bone bridge in the suture gap (5) . The risk of relapse increases with age because of tight interdigitation and ossification in the suture (1, 6) . Cranial suture expansion and remodelling are performed on patients with craniosynostosis to minimize deformities and to prevent increased intracranial pressure that can lead to impaired neurocognitive development, among other symptoms (7, 8) . The treatment of synostotic sutures begins with a strip craniectomy performed in order to separate the cranial vault bones that have fused prematurely, followed by direct skull remodelling (9) or expansion using springs (10, 11) . Complications after a strip craniectomy include relapse and, most dramatically, failure of re-ossification and closure of the suture gap (12) . Various methods have been developed to improve the control of cranial suture expansion and post-expansion consolidation, such as prolonged retention (13, 14) , connective tissue remodelling (15, 16) , laser therapy (17) , and pharmacotherapy to induce bone formation (18, 19) .
Relaxin (RLN) is an insulin-like hormone that was first described as a factor that facilitates parturition by softening and lengthening the pubic symphysis and softening the cervix. It is produced by the corpora lutea in the ovaries in females and the testis in males. Apart from its physiological effects on male and female reproduction, it is known to affect connective tissue metabolism, especially in the cardiovascular system (20) . RLN is expressed in humans in three forms, RLN-1, -2, and -3, but is present only as Rln-2 and -3 in other mammals (21) . Human RLN-1 and -2, as well as Rln2 in other mammals, are commonly referred to as 'relaxin' (21) . RLN predominantly binds to the relaxin/insulin-like family peptide receptor (Rxfp)-1 or -2 with species specificity. In rodents, Rln is the main Rfxp1 ligand, although species-specific pharmacological interactions with Rxfp2 have also been observed (20, 21) . Both receptors trigger the 3′-5′-cyclic adenosine monophosphate (cAMP) activation signalling cascade, increase nitric oxide production and/or induce extracellular signal-regulated kinase (Erk) 1/2 phosphorylation. Rln exerts a variety of effects in different types of cells. Rxfp1 is expressed in fibroblasts and, through this receptor, RLN inhibits fibroblast proliferation and differentiation (22) , but increases the production of matrix metalloproteinase (MMP) 1, 2, 9, and 13 (23, 24) , resulting in a strong antifibrotic effect. Osteoclasts express Rxfp1 whereas osteoblasts and periferal blood mononuclear cells express both Rxfp1 and 2 (25, 26) . Rln influences bone metabolism by inducing osteoclastogenesis and the activation of mature osteoclasts by activation of nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB), receptor activator of NF-kappa-B (Rank), tartrate-resistant acid phosphatase (TRAP), and cathepsins through Rxfp1 (26, 27) . Moreover, our group previously reported that Rln induces osteogenic differentiation and increases mineralization through the activation of alkaline phosphatase (ALP), runt-related transcription factor 2 (Runx2), and bone morphogenetic protein 2 (Bmp2) by activation of the ERK signalling pathway, mainly through Rxfp2 (25) , and that Rxfp1 and -2 mRNA is expressed in developing craniofacial skeletal tissues (28) .
Liposomes are lipid, multi-layer drug delivery systems that are non-toxic and impermeable to many solutes. Liposomes can contain drugs or other materials within the lipid bilayer, in the aqueous space inside the lipid periphery or attached to the lipid surface of the liposome, and efficiently localize the delivery of their contents (29) . Liposomes cannot cross the blood-brain barrier, which makes them suitable for the delivery of drugs to cranial sutures without affecting the central nervous system.
On the basis of these prior studies, we hypothesized that the antifibrotic effect of RLN might induce the disorganization and degradation of connective tissue in sutures during suture expansion and that the osteoclastogenic effect of RLN might increase the rate of remodelling of calvarial bones. Moreover, we predicted that the osteogenic effect of RLN might accelerate the formation of the bone bridge, which would then stabilize the suture gap. We examined the effect of RLN carried by liposomes on expansion range, collagen staining, Rxfp1 and -2 expression, bone mineral density (BMD) and volume, osteoclastogenesis, and osteogenesis, shortly after expansion was initiated and during the early stages of expansion consolidation and suture gap remodelling.
Materials and methods

Animals
This study was performed on twenty-four 8-to 10-week-old wild type inbred C57BL/6J male mice that were divided into four groups, each consisting of six mice. The experiments were performed at the Center for Experimental Animals of the Tokyo Medical and Dental University, in accordance with the guidelines specified by the Institutional Animal Care and Use Committee (# 0130010A).
Construction of liposomes containing RLN
Bilayer cholesterol liposomes were used to transport recombinant human relaxin 1 (RLN1) (25) to the sagittal suture. The nano-sized liposomes (diameter < 100 nm) containing 47.6 µg/ml of RLN1, nanometre-sized magnetite (ferric oxide) particles, and the fluorescent dye Cy3, used for experimental imaging purposes, were developed by Glycolipo™ (Katayama Chemical Industries, Osaka, Japan). The liposomes were prepared using the improved collate dialysis method (30) . Human serum albumin-bound Cy3-NHS ester (GE Healthcare, Little Chalfont, Buckinghamshire, UK) and magnetic iron (EMG707; Ferrotec, Tokyo, Japan) were added to the liposomes using the coupling method. Finally, RLN1 (R&D Systems, Minneapolis, Minnesota, USA) was attached to the liposomal surface using 3,3′-dithiobis (sulfosuccinimidyl propionate) (DTSSP; Pierce Biotechnology, Rockford, Illinois, USA). The particle size and zeta-potential were measured with a Zetasizer Nano-S90 analyzer (Malvern, Malvern, Worcestershire, UK), and the RLN concentration was estimated by enzyme-linked immunosorbent assay.
Sagittal suture expansion
Sagittal suture expansion was carried out for 1 week ( Figure 1A ) by using single-coil springs made of 0.014-inch orthodontic wires consisting of a cobalt-chromium-nickel alloy (Elgiloy; Rocky Mountain Orthodontics, Denver, Colorado, USA). The mice were anaesthetised by intraparenteral injection of 40 mg/kg of 2,2,2-tribromoethanol (Avertin; Sigma-Aldrich, Saint Louis, Missouri, USA), after which the scalps were shaved, and 10 µl of 2 per cent lidocaine hydrochloride with epinephrine (1:1 00 000) was injected subcutaneously into each side of the sagittal suture. One small cut was made on each side of the sagittal suture with a dissection scissor to expose the parietal bones, and two holes were drilled on both parietal bones with a distance of 5 mm between them by using a 26-gauge needle. The expansion spring was positioned to cross over the sagittal suture and into the holes, to exert 20 gf, and allow a maximum of 2 mm of expansion. The spring was secured to the calvarial bones using a drop of cyanoacrylate adhesive gel (Aron Alpha; Toagosei, Tokyo, Japan) on each side. In the nonexpansion group, a passive expansion spring that did not exert tension was used. The expansion group (expanded without any injection), phosphate-buffered saline (PBS) group (expanded with injections of 10 µl of PBS in the suture area), and RLN-Lipo group (expanded with injections of 10 µl of 20 ng/ml RLN-Lipo solution in PBS) had an active expansion spring, as described above. The expansion spring was activated immediately after injection of PBS or RLN-Lipo solution in PBS, or immediately after securing the springs with cyanoacrylate adhesive in the group expanded without injection.
Tissue preparation
Three mice from each group were sacrificed 48 hours following the initial expansion, and the remaining three mice were sacrificed following 1 week of expansion ( Figure 1A ). The animals were euthanized by neck dislocation following sedation with diethyl ether. The calvaria were dissected and fixed overnight in 4 per cent paraformaldehyde (Wako, Osaka, Japan) solution in PBS at 4°C. Special care was taken to maintain the integrity of the sagittal sutures by dissecting all of the surrounding cranial sutures together. Samples intended for histological assessment were demineralised in 0.5 M ethylenediaminetetraacetic acid (EDTA; Wako) at a pH of 8.0, processed by alcohol dehydration, embedded in paraffin, serially sectioned at 7-µm intervals, and then placed on glass slides. Samples intended for computed tomography assessment were stored whole in 70 per cent ethanol at 4°C following fixation. The calvarial sections on the glass slides were deparaffinized with xylene and rehydrated in a series of incubations in ethanol. Following histological staining, the slides were dehydrated with ethanol followed by xylene, mounted with cover slips with a xylene-based mounting medium, and observed under an inverted optical microscope (Axiovert 200M; Carl Zeiss, Jena, Germany). The images were captured with an AxioCam HRc camera (Zeiss), using the AxioVision software, version 4.8 (Zeiss). Histological staining was performed in duplicates for all samples.
Histological staining
The deparaffinized calvarial sections were stained with Harris' haematoxylin, rinsed with tap water, differentiated with acid alcohol, rinsed again, and then cleared in 0.2 per cent ammonia. The slides were dehydrated and counter-stained with Eosin Y (Wako). Tartrate-resistant alkaline phosphatase (TRAP) activity was estimated to determine the degree of osteoclast maturation and bone resorption in the parietal bones and sagittal suture using a TRAP-ALP staining kit (Wako) following the manufacturer's recommendations. The collagen content was examined in the parietal bones and sagittal sutures using Verhoeff-Van Gieson staining (VVG; Elastic Stain Kit; Sigma-Aldrich) according to the manufacturer's instructions. VVG staining was duplicated to rule out procedural or sample specific factors that could affect the results.
Immunohistochemistry
Immunohistochemistry was performed to assess the changes in Rxfp1 and -2 expression in the parietal bone and sagittal suture tissue during expansion with or without RLN treatment. The receptors were detected using an anti-RXFP1 polyclonal antibody (HPA027067; Sigma-Aldrich) and anti-RXFP2/LGR8 polyclonal antibody (LS-A4752; LifeSpan BioSciences, Seattle, Washington, USA) at concentrations of 1:150 and 1:100, respectively. The antigen was retrieved with sodium citrate buffer at 95°C (pH 6.0) for 40 minutes. The slides were cooled and treated with 0.3 per cent hydrogen peroxide at room temperature for 15 minutes. Following blocking with normal goat serum, the slides were incubated overnight at 4°C with the primary antibody followed by a biotinylated secondary goat antirabbit IgG antibody and the avidin-biotin complex provided with the VECTASTAIN Elite ABC (rabbit IgG) kit (Vector Laboratories, Burlingame, California, USA) according to the manufacturer's recommendations. The reaction was developed with an immunoperoxidase staining system (Histofine® Simple Stain™ DAB; Nichirei Biosciences, Tokyo, Japan) and counterstained with methyl green.
Micro-computed tomography
Calvarial samples stored in ethanol were trimmed prior to scanning. All samples were scanned at 90 kV, 150 µA, and 39 µm/voxel, with filtration through a 0.1-mm brass plate, using a high-resolution X-ray µCT system, SMX-100CT (Shimadzu, Kyoto, Japan). BMD was calculated from raw data by using the three-dimensional image analysis software TRI/3-D-BON (Ratoc, Tokyo, Japan). Portions with a BMD greater than 350 mg/cm 3 were considered bones. Images acquired to determine the position of the skull were calibrated on the basis of the parietal bone and midline. The bone volume (BV) and BMD around the sagittal suture were calculated. The regions of interest (31) consisted of five sections in the sagittal suture of each sample and were defined as rectangles of 30 pixels × 5 pixels in the midline region ( Figure 3A ).
Colourimetric analysis
The relative expression of TRAP staining was analysed by digital colourimetry using Image J software for image data processing (National Institutes of Health, USA). The images were converted to 8-bit RGB stacked files. The image size was normalized to 820.25 pixels/mm and 3-81 threshold levels. Area fractions were measured and converted to optic density ratios using 255 as the maximum intensity standard value.
Statistical evaluation
The differences in quantitative data from the calliper measurements of total expansion, TRAP optical density, BV, and BMD were analysed by Kruskal-Wallis and Dunn's post hoc tests using the GraphPad Prism software for Mac, version 6.0 (GraphPad Software, Inc., San Diego, CA, USA). The data are expressed as the medians and the first and third quartiles; P-values of less than 0.05 were considered to represent a significant difference.
Results
The distance between the two perforations, where the expansion springs were positioned and activated on the calvaria, was measured using an orthodontic calliper following 48 hours of expansion. Only the RLN-Lipo group showed significantly greater expansion than the non-expansion group; however, no significant difference in expansion was observed between the PBS and RLN-Lipo groups ( Figure 1B ). Histological observation revealed less collagen staining in the suture of the RLN-Lipo group ( Figure 1C) . The micro-computed tomography (µCT) images show dorsal views of the expanded sagittal sutures after 48 hours ( Figure 1D ). Areas surrounding the expanded sagittal sutures of the non-expansion and RLN-Lipo groups are warmer in colour, therefore, they are expected to have higher BMD values.
Rxfp1 was expressed in the mid-sutural fibrous tissue and parietal bones of all the groups (Figure 2A, 2C, 2E , 2G, 2I, 2K, 2M, and 2O); however, its expression was only upregulated in the RLNLipo group (Figure 2M and 2O) . Rxfp2 was not expressed in the mid-sutural fibrous tissue or parietal bones in the non-expansion group ( Figure 2B and 2D ) but was expressed in the parietal bones in the expansion, PBS, and RLN-Lipo groups ( Figure 2H , 2L, and 2P). Rxfp2 expression was upregulated in the RLN-Lipo groups ( Figure 2N and 2P) .
BMD and BV were calculated after 1 week of active expansion. Both BMD and BV were significantly higher in the RLN-Lipo group than in the PBS groups ( Figure 3B-E) . There was no significant difference between the non-expansion and RLN-Lipo groups ( Figure 3B and 3C) , which indicates that the bone osteoid of the RLN-Lipo group was comparable to intact calvarial bones. More TRAP-positive areas and multinucleated cells were observed in the RLN-Lipo group than in all the other groups, suggesting that active bone remodelling occurred in the newly formed osteoid tissue of the RLN-treated samples ( Figure 3F) . No difference in collagen staining was observed between any of the groups following 1 week of active expansion (data not shown). The fibroblasts were organized in a lattice, with long dendritic extensions towards the adjacent parietal bones, in the RLN-Lipo group ( Figure 3G) ; however, they were randomly organized, with short rounded extensions towards the adjacent parietal bones, in the expansion and PBS groups ( Figure 3G ).
Discussion
Our preliminary study using primary osteoblast cells isolated from wild-type murine embryonic calvarial tissue revealed that RLN (20 ng/mL) enhanced the expression of Rxfp1 and -2 mRNA (Supplementary Figure 1) . Additionally, we demonstrated that RLN (20 ng/ml) enhanced osteoblastic differentiation and caused abnormal mineralization and extracellular matrix metabolism through Rxfp2 (25) . Therefore, we performed the current in vivo study using RLN at a concentration of 20 ng/ml. Cy3 was not detected at any time point under the current in vivo experimental conditions; presumably, liposomes are shed into the bloodstream relatively early after administration. Currently, we are developing a magnetic control system for liposome localization in vivo.
Here, we present data suggesting that RLN treatment does not significantly increase expansion range; however, it accelerates osteoid tissue formation in the suture gap. These effects may have been mediated by Rxfp1 in the mid-suture fibrous tissue and by Rxfp1 and -2 in the parietal bone cells. Expansion of the sagittal suture requires rearrangement of the fibrous connection that holds the parietal bones together. RLN increases protease activity and disarranges the connective tissue in craniofacial sutures and the periodontal ligament (32, 33) . In this study, we used low doses of RLN which may not have been sufficient to obtain such dramatic effects, and RLN was administered immediately before expansion which may not have provided enough time for the hormone to produce significant differences between the expansion groups. However, a decrease in the collagen staining of the sutures was observed after 48 hours, which might suggest collagen content reduction that could have been mediated by Rxfp1 and -2, which inhibit collagen synthesis and increase MMP production (24) . Following immediate inflammatory response induced by active expansion, connective tissue repair, and angiogenesis at the expansion gap, bone formation is observed in the parietal bones in the direction of the expansion (34, 35) . Active bone formation usually begins after 3 weeks and is completed within 8 weeks (35) . In the current study, we observed early bone formation in the RLN-treated samples, where osteoid tissue of density similar to that of intact calvarial bones was detected in the expansion gap after 1 week. These effects may have been mediated by Rxfp2, which induces early osteoblast maturation and increases mineral deposition (25) , and was significantly upregulated following RLN treatment. Expression of Rxfp2 is predominant over Rxfp1 in osteoblasts and previous reports show that the receptor expression is upregulated during osteoblast differentiation (25) . Reports on the role of the receptors have shown that silencing of Rxfp1 affects gonad development and induces lung fibrosis (36) , whereas silencing of Rxfp2 results in an osteoporotic phenotype in addition to gonad development abnormalities (37) ; therefore, increased expression of Rxfp2 may lead to increase in BMD.
RLN has previously been used to accelerate orthodontic tooth movement (38) , maintain patency of synostotic sutures (39) , and reduce relapse following orthodontic treatment (33) , with successful results observed only in relapse control. It is possible that the intravenous administration of RLN, either at high concentrations or for a long period, could have affected the outcome of the RLN treatment. When applied intravenously, RLN is taken up by a number of organs and tissues that express Rxfp1 and -2 (20) . RLN acts in a dose-dependent manner, and high concentrations can cause nonspecific binding of RLN to receptors other than Rxfp1 and -2 (20) . Moreover, long-term administration of recombinant RLN leads to the production of antibodies against RLN (33) , which could interfere with the RLN treatment. Here, we used a single low dose of RLN administered locally with a nano-sized liposome that undergoes macrophage phagocytosis (29) . The macrophages themselves can be affected by RLN, which induces osteoclastogenesis of the peripheral blood mononuclear cells (PBMCs) (27) . We believe that, through this drug delivery method, RLN was effectively delivered to fibroblasts, osteoblasts, and PBMCs in and around the sagittal suture, where it played a crucial role in optimizing expansion.
Fibroblast shape is affected by the tensile forces applied on their surroundings. Fibroblasts found in stress-free, three-dimensional matrices develop long dendritic extensions that are believed to permit the fibroblasts to explore the surrounding surfaces and become The gray and coloured bars in A, D and E indicate BMD values, ranging from 100 to 700 mg/cm 3 ; *P < 0.05; **P < 0.005; P, parietal bone; scale bar in A, 2 mm; scale bars in F and G, 100 µm.
interconnected with each other to exchange information. On the other hand, tensile forces on the matrix induce the formation of flat, lamellipodial extensions (40, 41) . The long dendritic extensions observed on the fibroblasts of the RLN-Lipo group suggest that the samples in this group experienced lower residual tensile force than the other samples. RLN treatment did not significantly increase the expansion range; however, it accelerated tension relief and induced bone remodeling and rapid osteoid tissue formation following expansion. The sagittal suture tissue expressed Rxfp1, and its expression was increased following RLN treatment. However, Rxfp2 was only expressed in the parietal bone under tensile stimulation, and its expression was further increased by RLN treatment. Our results suggest that RLN might contribute to a reduction in relapse following suture expansion by inducing faster bone formation in the expansion gap.
Conclusions
Our in vivo results show that RLN could optimize suture expansion by stimulating rapid bone turnover in the expansion area. A further study using large animals and a larger sample size is required to show the detailed molecular mechanism in RLN-regulation of bone remodelling during and after expansion of craniofacial sutures.
Supplementary material
Supplementary material is available at European Journal of Orthodontics online.
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